Background
Objective
Study Design
Results
Conclusion
Key words
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to American Journal of Obstetrics & GynecologyReferences
- Epidemiology of urinary incontinence (UI) and other lower urinary tract symptoms (LUTS), pelvic organ prolapse (POP) and anal incontinence (AI).in: Abrams P. Cardozo L. Wagg A. Wein A. Incontinence 6th Edition. ICI-ICS. International Continence Society, Bristol, UK2017
- Lifestyle interventions for the treatment of urinary incontinence in adults.Cochrane Database Syst Rev. 2015; 12: CD003505
- Pelvic floor muscle training versus no treatment, or inactive control treatments, for urinary incontinence in women.Cochrane Database Syst Rev. 2018; 10: CD005654
- Mid-urethral sling operations for stress urinary incontinence in women.Cochrane Database Syst Rev. 2017; 7: CD006375
- A 12-week treatment with fractional CO2 laser for vulvovaginal atrophy: a pilot study.Climacteric. 2014; 17: 363-369
- Is there enough evidence to justify the use of laser and other thermal therapies in female lower urinary tract dysfunction? Report from the ICI-RS 2019.Neurourol Urodyn. 2020; 39: S140-S147
- Effect of single-treatment, surface-cooled radiofrequency therapy on vaginal laxity and female sexual function: the VIVEVE I randomized controlled trial.J Sex Med. 2017; 14: 215-225
- Vaginal Er:YAG laser application in the menopausal ewe model: a randomised estrogen and sham-controlled trial.BJOG. 2021; 128: 1087-1096
- Effect of fractional carbon dioxide laser vs sham treatment on symptom severity in women with postmenopausal vaginal symptoms: a randomized clinical trial.JAMA. 2021; 326: 1381-1389
- Statement from FDA Commissioner Scott Gottlieb, M.D., on efforts to safeguard women’s health from deceptive health claims and significant risks related to devices marketed for use in medical procedures for ”vaginal rejuvenation”.(Available at:)https://www.fda.gov/news-events/press-announcements/statement-fda-commissioner-scott-gottlieb-md-efforts-safeguard-womens-health-deceptive-health-claimsDate: 2018Date accessed: September 27, 2021
- The efficacy and safety of a single maintenance laser treatment for stress urinary incontinence: a double-blinded randomized controlled trial.Int Urogynecol J. 2022; ([Epub ahead of print])
- CO 2 Laser and radiofrequency compared to a sham control group in treatment of stress urinary incontinence (LARF study arm 3). A randomized controlled trial.Int Urogynecol J. 2022; ([Epub ahead of print])
- Fractional-pixel CO 2 laser treatment in patients with urodynamic stress urinary incontinence: 1-year follow-up.Lasers Surg Med. 2021; 53: 960-967
- Fractional CO 2 laser for treatment of stress urinary incontinence.Eur J Obstet Gynecol Reprod Biol X. 2019; 1100004
- First assessment of short-term efficacy of Er:YAG laser treatment on stress urinary incontinence in women: prospective cohort study.Climacteric. 2015; 18: 37-42
- Erbium:YAG laser treatment of female stress urinary incontinence: midterm data.Int Urogynecol J. 2020; 31: 1859-1866
- Comparison between erbium-doped yttrium aluminum garnet laser therapy and sling procedures in the treatment of stress and mixed urinary incontinence.World J Urol. 2019; 37: 885-889
- Vaginal therapy of mild and moderate stress urinary incontinence using Er:YAG laser: a real treatment option.Arch Gynecol Obstet. 2019; 300: 1645-1650
- Effects of laser procedure for female urodynamic stress incontinence on pad weight, urodynamics, and sexual function.Int Urogynecol J. 2017; 28: 469-476
- Non-ablative Er:YAG laser therapy effect on stress urinary incontinence related to quality of life and sexual function: a randomized controlled trial.Eur J Obstet Gynecol Reprod Biol. 2018; 224: 153-158
- IUGA committee opinion: laser-based vaginal devices for treatment of stress urinary incontinence, genitourinary syndrome of menopause, and vaginal laxity.Int Urogynecol J. 2019; 30: 371-376
- Validation of two global impression questionnaires for incontinence.Am J Obstet Gynecol. 2003; 189: 98-101
- ICIQ: a brief and robust measure for evaluating the symptoms and impact of urinary incontinence.Neurourol Urodyn. 2004; 23: 322-330
- The Bristol Female Lower Urinary Tract Symptoms questionnaire: development and psychometric testing.Br J Urol. 1996; 77: 805-812
- Short forms to assess life quality and symptom distress for urinary incontinence in women: the incontinence impact questionnaire and the urogenital distress inventory. Continence Program for Women Research Group.Neurourol Urodyn. 1995; 14: 131-139
- A short form of the Pelvic Organ prolapse/Urinary Incontinence Sexual Questionnaire (PISQ-12).Int Urogynecol J Pelvic Floor Dysfunct. 2003; 14: 164-168
- Comparison of two questionnaires for assessing the severity of urinary incontinence: the ICIQ-UI SF versus the incontinence severity index.Neurourol Urodyn. 2009; 28: 411-415
- ICIQ symptom and quality of life instruments measure clinically relevant improvements in women with stress urinary incontinence.Neurourol Urodyn. 2015; 34: 747-751
- Identification of the Urogenital Distress Inventory-6 and the Incontinence Impact Questionnaire-7 cutoff scores in urinary incontinent women.Health Qual Life Outcomes. 2021; 19: 87
- Association between risk-of-bias assessments and results of randomized trials in Cochrane reviews: the ROBES meta-epidemiologic study.Am J Epidemiol. 2018; 187: 1113-1122
- Light and energy based therapeutics for genitourinary syndrome of menopause: consensus and controversies.Lasers Surg Med. 2017; 49: 137-159
- Pixel CO 2 laser for the treatment of stress urinary incontinence: a prospective observational multicenter study.Lasers Surg Med. 2021; 53: 514-520
- Long-term effect of thermoablative fractional CO 2 laser treatment as a novel approach to urinary incontinence management in women with genitourinary syndrome of menopause.Int Urogynecol J. 2018; 29: 211-215
- The evidence for laser treatments to the vulvo-vagina: making sure we do not repeat past mistakes.Aust N Z J Obstet Gynaecol. 2018; 58: 148-162
- Laser vaginal tightening complications: report of three cases.Lasers Surg Med. 2019; 51: 757-759
Article Info
Publication History
Publication stage
In Press Journal Pre-ProofFootnotes
The authors report no conflict of interest.
Partial funding was obtained during the study from the Continence Foundation of Australia ( M21005 / 3176612 ). The funder did not play any role in conducting the study, writing the manuscript, or the decision to submit for publication.
Clinical trial registration through Australian New Zealand Clinical Trials Registry
i) Date of registration: January 18, 2017
ii) Date of initial participant enrolment: February 1, 2017
iii) Clinical trial identification number: ACTRN12617000099325
iv) URL of registration site: www.anzctr.org.au
v) Data sharing information: Not available
Cite this article as: Alexander JW, Karjalainen P, Ow LL, et al. CO2 surgical laser for treatment of stress urinary incontinence in women: a randomized controlled trial. Am J Obstet Gynecol 2022;XX:x.ex–x.ex.